Phone is the only working channel for a live agent
In the SURMOUNT-1 trial, participants on the highest dose of tirzepatide lost an average of 22.5 percent of their body weight at 72 weeks (Jastreboff et al., NEJM , 2022), compared to roughly 15 percent with semaglutide 2.4 mg in the STEP 1 trial (Wilding et al., NEJM , 2021)
If you fall within the inclusion criteria, our experienced medical provider will review if either Semaglutide or Tirzepatide injections is for you if you fall within the criteria set forth by FDA
Your journey starts today, as easy as 1-2-3 Free Evaluation Affinity is here to listen to your symptoms and health goals
Current discoveries and management of psammomatous melanotic schwannoma
For example, most major GLP-1 trials have enrolled people with obesity or diabetes